The anticarcinogenic conjugated fatty acid c9, t11-C18:2, or rumenic acid, in human milk: Amounts and effects

14Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The conjugated linoleic acid (CLA) c9, t11-C18:2 has been detected in human milk by gas-liquid chromotography (GLC) using standards for tentative identification. The amounts found were: 5.5mg/g fat, Australia, 1988; and 3.6mg/g fat, Idaho, 1997. We also employed GLC and standards and confirmed the identity of coeluting peaks by mass spectrometry. Our values were 1.8 ± 0.02mg/g fat. CLA inhibits growth of several cancers, is antiatherosclerotic, partially overcomes catabolic responses to endotoxin injection, enhances weight gain and improves feed efficiency in rats, and modulates immune response and bone deposition. The dietary sources are ruminant-derived foods, particularly aged cheese.

Cite

CITATION STYLE

APA

Jensen, R. G., & Lammi-Keefe, C. (2001). The anticarcinogenic conjugated fatty acid c9, t11-C18:2, or rumenic acid, in human milk: Amounts and effects. In Advances in Experimental Medicine and Biology (Vol. 501, pp. 153–156). Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-1371-1_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free